Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Synthetic polymer and natural extracellular matrix composite material, artificial blood vessel and preparation method thereof

A technology for synthesizing polymers and composite materials, applied in the fields of degradable synthetic polymers and natural extracellular matrix composite materials, artificial blood vessels and their preparation, can solve problems such as weak mechanical properties and instability, meet mechanical requirements, improve Improvement of processability, biocompatibility and bioactivity

Pending Publication Date: 2019-09-06
NANKAI UNIV
View PDF8 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The synthetic polymer components can choose one or more material ratios, and can be prepared by various technologies such as electrospinning, wet spinning, melt spinning, 3D printing, phase separation, particle leaching, etc. Scaffold materials with fiber diameters, different fiber arrangements, different pore diameters, and different pore structures can provide artificial blood vessels with good mechanical properties, controllable spatial structures, and suitable degradation speeds, thus solving the problem of pure ECM materials used as artificial blood vessels. Weak mechanical properties, compact structure, instability, etc.; the natural extracellular matrix components can choose different kinds of animal-derived vascular tissue (such as pig, bovine arteries, veins, etc.) or human donor vascular tissue (such as umbilical cord etc.), which have a wide range of sources, and can flexibly adjust the composition and content of ECM according to the needs, because ECM contains a large amount of glycosaminoglycans, collagen and exosomes (which contain a variety of micro RNAs related to tissue regeneration and development) and other natural Active ingredients, which can make the original inert synthetic degradable polymer materials have good biological activity, which can regulate the post-implantation inflammatory response (such as the polarization of macrophages to the pro-regenerative M2 type) and promote tissue cell proliferation Biological effects such as maturation, so that the artificial blood vessels implanted in the body can achieve good regeneration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic polymer and natural extracellular matrix composite material, artificial blood vessel and preparation method thereof
  • Synthetic polymer and natural extracellular matrix composite material, artificial blood vessel and preparation method thereof
  • Synthetic polymer and natural extracellular matrix composite material, artificial blood vessel and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Preparation of poly-L-lactide-caprolactone (PLCL) and extracellular matrix (ECM) composite bilayer (oriented inner layer and random outer layer) artificial blood vessel

[0072] Preparation of the inner layer of the artificial blood vessel: Weigh 1.0g of ECM powder and add it to 10ml of hexafluoroisopropanol, use a homogenizer to further homogenize the ECM powder, then weigh 2.0g of PLCL into the solution, stir and dissolve overnight at room temperature, A mixed solution with a concentration fraction of PLCL 20% (mass / volume) and ECM 10% (mass / volume) was prepared. Artificial blood vessels were prepared by wet spinning in a fume hood at room temperature. A stainless steel receiving rod with a diameter of 2.0 mm was installed on the wet spinning apparatus, the mixed solution was sucked into the syringe, the syringe was installed on the syringe pump, and the needle of the syringe was placed on the syringe. In the spinning coagulation bath at a position 5cm away from the r...

Embodiment 2

[0081] Preparation of Polycaprolactone (PCL) and Extracellular Matrix (ECM) Composite Electrospun Random Artificial Blood Vessels

[0082]Weigh 0.2g of ECM powder and add it to 10ml of chloroform-methanol mixed solution (volume / volume=5:1), use a homogenizer to further homogenize the ECM powder, then weigh 1.0g of PCL and add it to the solution, stirring at room temperature to dissolve Overnight, a mixed solution of PCL 10% (mass / volume) and ECM 2% (mass / volume) was prepared. Artificial blood vessels were prepared by electrospinning in a fume hood at room temperature, and a stainless steel receiving rod with a diameter of 3.0 mm was installed on the electrospinning machine and grounded. Inhale the mixed solution into the syringe, install the syringe on the syringe pump, place the needle of the syringe at a distance of 15 cm from the receiver, and apply a voltage of 10 kV to the needle using a high-voltage direct current power supply. Set the advancing speed of the syringe pum...

Embodiment 3

[0084] Preparation of Degradable Polyurethane (PU) and Extracellular Matrix (ECM) Composite Casting Artificial Blood Vessels

[0085] Weigh 2.0g of ECM powder and add it to 10ml of N,N-dimethylformamide solution, use a homogenizer to further homogenize the ECM powder, then weigh 0.2g of PU into the solution, stir and dissolve overnight at room temperature, and prepare The concentration fraction is the mixed solution of PU2% (mass / volume), ECM 20% (mass / volume). The mixed solution was poured into a polytetrafluoroethylene (PTFE) mold of concentric cylinders (inner cylinder diameter 4.0 mm, outer cylinder diameter 4.8 mm), and placed in a vacuum desiccator to remove the solvent. After completion, the tube is removed from the mold, thereby obtaining the prosthetic blood vessel product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a degradable synthetic polymer and natural extracellular matrix composite material, an artificial blood vessel and a preparation method thereof. Degradable synthetic polymer components during preparation can be selected from one or more materials to perform proportioning; support materials with different fiber diameters, different fiber arrangement, different apertures anddifferent pore structures can be prepared through various technologies such as electrospinning, wet spinning, melt spinning, 3D printing, pouring, phase separation and particle leaching; and naturalextracellular matrix components are wide in sources, can be selected from vascular tissues (such as the arteries and veins of pigs and cows) of different species of animal sources or the vascular tissues (such as umbilical cords) of human donors, and can flexibly adjust the components and content thereof according to needs. The composite material and the artificial blood vessel prepared by the preparation technology can have good mechanical properties, controllable space structures, appropriate degradation velocity and excellent biocompatibility and biological induction activity; and the composite material, the artificial blood vessel and the preparation method are simple in preparation technology, high in controllability, mild in condition and suitable for large-scale industrial production.

Description

technical field [0001] The invention belongs to the field of tissue engineering, and in particular relates to a composite material of degradable synthetic macromolecule and natural extracellular matrix, an artificial blood vessel and a preparation method thereof. Background technique [0002] Vascular disease is the disease with the highest fatality rate in the world. The occurrence of this disease is often due to the narrowing or blockage of blood vessels, which leads to reduced blood flow and lack of nutrients, which damages tissues or organs. It usually manifests as coronary heart disease, cerebrovascular disease, peripheral artery disease, etc. disease and deep vein thrombosis. According to the prediction of the World Health Organization, by 2030, the number of people dying of cardiovascular-related diseases in the world will increase to 23.3 million each year. Vascular transplantation is still a routine method for the treatment of such diseases. The first choice for th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/18A61L27/36A61L27/50A61L27/56A61L27/58
CPCA61L27/3633A61L27/18A61L27/507A61L27/56A61L27/58A61L27/48C08L67/04C08L71/02
Inventor 孔德领董显豪朱美峰
Owner NANKAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products